Back to library
Small MoleculePhase2

NMN / NR (NAD+ Precursors)

en-em-en / en-ar

Research profile · How we handle evidence

Category

Small Molecule

Compound type

Phase / Status

Phase2

Active research and commonly marketed as a dietary supplement; not FDA approved as a drug for anti-aging or disease prevention.

Standard Dose

250-500mg/day (NMN) or 150-300mg/day (NR)

Once daily (morning)

Half-life

Converted to NAD+ rapidly (minutes to hours)

Plasma elimination

Route(s)

OR

Oral

Research Stage

Status Unknown

Research phase not specified; exercise appropriate caution.

Overview

NAD+ is involved in many cellular processes, including energy production and DNA repair. NMN and NR are precursors that may raise NAD+ levels, and early studies have evaluated effects on metabolism and wellness markers.

Plain-language summary

NAD+ is involved in many cellular processes, including energy production and DNA repair. NMN and NR are precursors that may raise NAD+ levels, and early studies have evaluated effects on metabolism and wellness markers.

Administration Routes

  • Oral

Also known as

NMNNicotinamide MononucleotideNRNicotinamide Ribosidethe NAD booster

Mechanisms

1

NAD+ precursor: NMN and NR are converted into NAD+ through salvage and related pathways. NAD+ availability influences NAD-dependent enzymes such as sirtuins (SIRT1-7) and PARPs.

Detailed mechanism

NMN/NR provide NAD+ precursors that can be converted via salvage pathways, influencing NAD-dependent enzymes involved in metabolism and DNA repair.

Safety

Side effects

  • Generally well tolerated in reported studies
  • Possible mild gastrointestinal discomfort at higher doses
  • Headache occasionally

Reported benefits

  • May increase NAD+ related biomarkers
  • Potential effects on metabolic and cellular maintenance pathways
  • Research continues to clarify efficacy for long-term outcomes

Safety profile

Safety depends on dose and population; monitor for side effects and consult a clinician if you have medical conditions.

Clinical trials

Phase 1–2 studies explore safety and potential metabolic effects.

Structure

View 3D structure

Verified structure

NMN / NR (NAD+ Precursors)

Exact 2D structure can be rendered from a PubChem-backed canonical SMILES string.

Verified via PubChemMatched by casNumber
Source: PubChemLookup: 1094-61-7InChIKey DAYLJWODMCOQEW-TURQNECASA-N
Chemical Formula
C11H15N2O8P (NMN)
Molecular Weight
334.22 g/mol (NMN)
CAS Number
1094-61-7
InChIKey
DAYLJWODMCOQEW-TURQNECASA-N

Stack Context

Stacks with

ResveratrolFisetinMetformin (with caution)BPC-157

Comparison context

NMN and NR are distinct NAD+ precursors; they may raise NAD+ through related pathways. Other compounds (e.g., resveratrol) can affect sirtuin activity via different mechanisms.

References

  1. 1

    Safety and metabolism of NMN in healthy adults

    2021

    View source
  2. 2

    NAD+ metabolism and its roles in cellular processes (Nature Reviews Molecular Cell Biology)

    2020

    View source
  3. 3

    Nicotinamide riboside and human metabolism (Nature Communications)

    2016

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.